The potential mechanisms of action of celecoxib are not androgen-linked, so it is reasonable to assume that they might not be reflected in PSA-based measures of FFS; on this basis, we continue long-term patient follow-up and avoid definitive statements relating to the overall efficacy of COX-2 inhibition and prostate-cancer survival in this setting. Here, PTGS2 is linked to Familial prostate cancer.